Company Filing History:
1 out of 20 
1 out of 13 Years Active: 2017
Title: Innovator Sophie Lerouge: Pioneering Solutions in Vascular Treatment
Introduction: Sophie Lerouge, an accomplished inventor based in Montreal, CA, has made significant contributions to medical technology with her innovations. With a focus on developing effective treatment options for vascular defects, her work exemplifies the intersection of science and compassion.
Latest Patents: Sophie Lerouge holds one patent for her invention titled "Embolizing Sclerosing Hydrogel." This innovative hydrogel comprises a unique formula including chitosan, hydrochloric acid, iopamidol, β-glycerophosphate disodium salt, and sodium tetradecyl sulfate. Designed to treat vascular defects, this hydrogel not only provides a method for treatment but also includes a kit for synthesizing the hydrogel, showcasing her commitment to improving patient outcomes.
Career Highlights: Throughout her career, Sophie has worked with notable companies, including Val-Chum, Limited Partnership and Socovar Sec. Her experience in these environments has allowed her to refine her skills and drive her innovations forward, benefitting both her personal growth and the medical community.
Collaborations: During her journey as an inventor, Sophie Lerouge has collaborated with skilled professionals such as Giles Soulez and Ahmed Fatimi. These partnerships have enabled her to enhance her research and development processes, leading to impactful advancements in her field.
Conclusion: Sophie Lerouge stands out as a visionary inventor dedicated to transforming the landscape of medical treatments for vascular conditions. Her patent, the Embolizing Sclerosing Hydrogel, represents not just a personal achievement, but a potential life-changing solution for patients worldwide. Through her collaborations and career milestones, Lerouge continues to inspire future generations of inventors and innovators.